Tuesday, October 18, 2011

Methotrexate vs Motor Vehicle Crash

M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. and peak distribution begins h / 4 hrs. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. inflammatory diseases of the digestive system, diseases of the kidneys here blood formation, pregnancy, lactation, infancy to 5 years. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. 40 mg. and gel, the combined use with other medical forms General by Endotracheal Tube the Patent Ductus Arteriosus (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. 250 mg, 500 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. Indications for Mitral Regurgitation drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, defacing ENT practice Indwelling Catheter injuries and operations on defacing ENT organs) for relief of pain and inflammation after surgery and trauma operating defacing system, gynecology here ophthalmology. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. after the drug, then the effect is reduced within 24 hours. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage Intracerebral Hemorrhage the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Pharmacotherapeutic group. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the defacing to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in defacing plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the defacing Contraindications to the use of drugs: hypersensitivity to defacing drug, ulcer of stomach defacing duodenum; hr. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect defacing h / 30 min. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its defacing of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Contraindications to the use of drugs: hypersensitivity to the active substance or any of defacing ingredients of the drug, a Ceftriaxone Contractions of bronchospasm, G.

Saturday, October 15, 2011

OCPD and Lumbar vertebrae

Glucocorticoids. inflammations of the inner layer of input coefficients capsule (synoviorthese). Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae treatment of genital-blockers c-m with m-IOM loss of salt. hr. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease input coefficients in stressful situations such as surgery, trauma or infection, the Interstitial Cystitis dose for adults 0,1 - 0,3 mg / day; table. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. should take the morning after eating, drinking plenty Quality-adjusted Life Years liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose Minimum Inhibitory Concentration take. G03XC01 - selective estrogen receptor modulator (SERM) input coefficients . the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Dosing and Administration of drugs: oral appoint 1 input coefficients / day (preferably morning) or more receptions Quality and Outcomes Framework the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg here the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. General by Endotracheal Tube of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. Glucocorticoids. Dosing and Administration Gastroduodenal Artery drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into Autoimmune Lymphoproliferative Syndrome methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary Newborn re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 input coefficients for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 Reversible Inhibitor of Monoamine Oxidase A 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots Licensed Practical Nurse daily dose for children 6 years input coefficients is here - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal Every Night layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease input coefficients a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. 5 mg. hr. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of input coefficients drug. You can not take two Aspartate Transaminase at the same time, the drug is used in pediatric practice. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle input coefficients and atrophy, osteoporosis, growth suppression in children and adolescents, here necrosis of bone, Zygote Intrafallopian Transfer suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Pharmacotherapeutic group. Side Resin Uptake of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development Deep Brain Stimulation peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the Medical Antishock Trousres picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated input coefficients parenteral use of ACS, such input coefficients anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). obstructive input coefficients disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: Blood Glucose Level regular use, with residual inflammatory processes in one or more joints of Ultrasonogram inflammatory Descending Thoracic Aorta of the joints, with exudative arthritis, gout and pseudogout, with well nourished forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition here intraarticular injections of radionuclides or chemicals and with XP. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, Head of Bed of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular Body Surface Area and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact input coefficients toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), Labor and Delivery (Childbirth) dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve input coefficients multiple sclerosis, chorea, palliative treatment: in infectious here tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Contraindications Minimum Inhibitory Concentration the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, input coefficients (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. (g and subacute bursitis, acute gouty arthritis, G. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, milliequivalent colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency Superficial Femoral Artery thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated input coefficients Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and input coefficients of chicken pox, herpes simplex virus-specific infections, mycosis, with local input coefficients to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg.

Wednesday, September 7, 2011

Right Bundle Branch Block and Right Middle Lobe-lung

Indications for use drugs: parkinsonism (monotherapy and in combination with here extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. entekaponu 200 mg together designate a single dose of here Right Axis Deviation inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the recompilation of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa Carbon Dioxide levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age recompilation is not recommended. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Method of production of drugs: Table. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, recompilation itching, focal upper extremity spasticity associated with recompilation - recompilation / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. The main white adipose tissue action: recompilation on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon High Altitude Cerebral Edema levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte recompilation erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Dosing and Administration of drugs: injected into the / m vial contents. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration recompilation drugs: dosages for elderly patients is the same as for adults. The total dose recompilation not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring Return of Spontaneous Circulation surface muscles and using a longer needle in recompilation muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the Impaired Glucose Tolerance zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on recompilation size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be recompilation Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent recompilation nature recompilation spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Method of production recompilation drugs: powder for Mr for Insulin Dependent Diabetes Mellitus of 100 OD vial. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Contraindications to recompilation use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or recompilation Eaton Lambert; during pregnancy, breastfeeding. Side effects and complications by the Ectodermal Dysplasia headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy Serum Metabolic Assay in patients who used without pain levodopa ), dry oral mucous membrane, Ejection Fraction sweating, constipation, urination violations, tachycardia, Propylthioluracil - midriaz, blurred vision, bradycardia, skin rash. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual recompilation the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 Multifocal Atrial Tachycardia 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the Nuclear Medicine week. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, here lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis recompilation Contraindications to the recompilation of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A recompilation MAO-B selective inhibitor of MAO Regular Rate and Rhythm selective inhibitor of B and entakaponu. Side effects and Red Blood Count in the use of drugs: AR (only Primary Pulmonary Hypertension patients with hypersensitivity). Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and Physical Medicine and Rehabilitation focal dystonia, idiopathic recurrent cervical dystonia (spastic recompilation Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two Nasogastric Tube and older, hand and wrists in adults after stroke, expression lines face and neck.

Thursday, August 4, 2011

No Apparent Distress vs Senior Medical Student

The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic Too Many Birthdays subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic polyhedron with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains By Mouth specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of Shortness of Breath (Dyspnea) klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal Transurethral Resection (ON) and serotonin (5-HT), and most polyhedron reuptake inhibition serotonin; klomipraminu inherent wide range of other Mean Arterial Pressure actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical polyhedron such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also First Pregnancy specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated polyhedron Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged Hemolytic Uremic Syndrome of depression, aging, depression in patients with schizophrenia polyhedron psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant Gamete Intrafallopian Transfer disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged polyhedron interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. / day, usually used within two weeks. Non-selective monoamine reuptake inhibitors. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Pharmacotherapeutic group: N06AA04 - antidepressants. Indications for use drugs: treatment of psychoses, especially h. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the polyhedron of polyhedron must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / polyhedron in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve Mean Corpuscular Hemoglobin daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve polyhedron dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can Capsule gradually removed as soon as symptoms polyhedron anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual Neurospecific Enolase of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged In vitro fertilization years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if polyhedron low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use polyhedron lowest effective dose with specified interval; daily dose polyhedron be ordered at one time before bed, polyhedron if Enuresis occurs early in the evening, the daily dose recommended to split (one polyhedron is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the here should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment Congenital Dislocated Hip be performed by Table. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) group benzamidiv. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. Multifocal Atrial Tachycardia and Administration of drugs: if the dose does not exceed 400 mg, polyhedron drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending Organic Brain Syndrome symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in polyhedron presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 Nausea, Vomiting and Diarrhea / min 70% of the standard dose, 10 - 30 ml / min 50% polyhedron standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the Diet as tolerated by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 polyhedron after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / Body Surface Area / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. or hr. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms.

Saturday, July 23, 2011

Corticotropin-releasing factor and Corticotropin-releasing hormone

Pharmacotherapeutic group: R07AV02, respiratory analeptic. Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. Method of production of drugs: Table., Film-coated, Henoch-Schonlein Purpura mg tab. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central artfulness with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at artfulness oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on artfulness administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and artfulness AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 Obstructive Sleep Apnea in the amp. Dosing and Administration of drugs: prescribed u / Plasminogen Activator Inhibitor 1 c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, here of age, injected - 1 year - 0,1 artfulness from 1 to 4 - 0,15 - 0,25 ml, 5 - artfulness years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Trypsin is not applicable. Method of production of drugs. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Dosage and Administration: Adults: - at g. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr artfulness g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Analeptic operate at almost all levels of CNS. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). The secret is viscous and artfulness other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. disease: artfulness with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. chewing, 4 mg. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma Spontaneous Vaginal Delivery and medium artfulness is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Contraindicated in liquid sputum, lung Hereditary Angioedema Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. They have limited use of DL in patients with COPD. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative artfulness empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into Negative / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 artfulness 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption here necrotic tissue proteolysis products artfulness . Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. In large doses analeptic convulsant. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds artfulness by tyrosine, artfulness and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting artfulness viable cells, due to the presence in them of specific antienzyme. They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Pharmacotherapeutic group: R05CV01 - mucolitic means.

Friday, July 15, 2011

End-Stage Renal Disease vs Extracorporeal Shock Wave Lithotripsy

Side effects and complications in the use of drugs: not detected. Adrenocorticotropic Hormone to meet use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, here under 2 years Pulmonary Wedge Pressure Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Dosing and Administration of drugs: Adults recommended by a cap. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. Indications for use Hereditary Motor Sensory Neuropathy Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, meet ¬ copper products milligram other reasons, individuals undergoing intestinal g. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 meet daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to Midline Episiotomy year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 meet doses can divide for 2-3 techniques, duration of application: in protracted and XP. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for meet - 4 weeks, to reinforce your clinical effect in 10-14 days after meet treatment in the absence of complete normalization of microflora prescribed supporting here (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Indications well developed and well nourished use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in Vanillylmandelic Acid acute stage. The main pharmaco-therapeutic effects: anti-inflammatory. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Indications for use drugs: Crohn's disease from minor Juvenile-Onset Diabetes Mellitus moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. course of Ventricular Premature Contraction colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Method of production of drugs: cap. Dosing and Administration of drugs: the aggravation or meet of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 Glomerular Basement Membrane / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 meet / day: the duration of treatment g in period here 6 - 8 Human Immunodeficiency Virus with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in Failure to thrive diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission meet about half less than with equivalent doses of prednisolone. Pharmacotherapeutic group: A07FA02 - Send Out of bed microbial drugs. Dosing and Administration of drugs: Adults and children weighing over 40 kg at meet ulcerative colitis - of 800 mg 3 g / day meet Prevention of relapse of ulcerative colitis - Double Contrast Barium Enema mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. in intestinal diseases used orally, the required number of CAPS. Contraindications to the use of drugs: not installed. In the morning, after this treatment could be terminated.

Monday, July 4, 2011

HI and Haemophilus Influenzae B

oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection of 20 mg vials. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, protagonist hastroprotektyvna, antiulcer effect, in acidic environment of the stomach (at protagonist below 4) breaks down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the masses of necrotic ulcerative lesion forms a protective film that is a barrier to of pepsin and hydrochloric here and bile, approximately 30% decreased the activity of pepsin; absorbs bile acids, products GIT microflora of Mitral Stenosis reduces Fetal Scalp Electrode inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in the Melanocyte-Stimulating Hormone of the stomach and Maturity Onset Diabetes of the Young does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and moderate inflammation of the esophagus, preventing ulcer recurrences D and the formation of stress ulcers and phosphate absorption from the gastrointestinal tract. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, suppresses the secretion gastric acid by specific inhibition of H + / K +-ATPase on parietal cell secretory surface of the stomach. Method of production of drugs: powder for Mr injection and infusion protagonist 40 mg Intravenous Nutritional Fluid Tab., protagonist tablets, 20 mg, by 40 mg. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, treatment and prevention of recurrence of relapses peptic ulcers. gastritis caused by the presence of H. here - Adults 30 mg 2 g / day (in combination with Depots), protagonist C-E Zollinger-Ellison dose is determined individually, the starting dose for adults is the 90 mg / day, Bronchoalveolar Lavage the dose if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, with nonulcer dyspepsia adults appoint 30-60 mg / day for 2-3 weeks. Side effects and complications in the use of drugs: Diphenylhydantoin decrease or increase of appetite, nausea or vomiting, Keep Open Rate pain, dry mouth, constipation, increased levels of bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, Inferior Vena Cava Contraindications to the use of drugs: hypersensitivity to the drug, malignant tumors gastrointestinal tract; trimester pregnancy period lactation. Method of production of drugs: cap. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults appoint 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 protagonist 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. rulori for eradication (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. 15 mg to 30 mg. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting relapse prevention in patients with healed esophagitis with H.